Chemed Corporation's board of directors has authorized an additional $300 million for share repurchases, expanding the company's capital allocation strategy as it continues to return value to shareholders. The authorization provides flexibility for the company to acquire its own shares through open market purchases, funded via operational cash flow and available borrowing capacity under its revolving credit facility.
Concurrently, Chemed declared a quarterly dividend of $0.60 per share, scheduled for payment on March 13, 2026. This dividend represents the company's 219th consecutive quarterly distribution, underscoring its commitment to consistent shareholder distributions across its 54-year tenure as a publicly traded entity.
The dual capital return initiatives reflect Chemed's confidence in its operational performance and cash generation capabilities. The company, which operates in the healthcare services sector, has maintained regular dividend payments through various market cycles, demonstrating financial stability and disciplined capital management.